Cryoport, Inc. (CYRX)
16.92
-0.43
(-2.48%)
USD |
NASDAQ |
Oct 08, 16:00
16.89
-0.03
(-0.18%)
After-Hours: 20:00
Cryoport EPS Diluted (Quarterly) : -0.2033 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2033 |
| March 31, 2026 | -0.2291 |
| December 31, 2025 | -0.212 |
| September 30, 2025 | -0.1724 |
| June 30, 2025 | -0.2683 |
| March 31, 2025 | -0.2799 |
| December 31, 2024 | -0.4166 |
| September 30, 2024 | -0.0242 |
| June 30, 2024 | -1.621 |
| March 31, 2024 | -0.4262 |
| December 31, 2023 | -1.315 |
| September 30, 2023 | -0.3122 |
| June 30, 2023 | -0.4179 |
| March 31, 2023 | -0.1566 |
| December 31, 2022 | -0.2358 |
| September 30, 2022 | -0.1508 |
| June 30, 2022 | -0.2291 |
| March 31, 2022 | -0.3102 |
| December 31, 2021 | -5.457 |
| September 30, 2021 | -0.1848 |
| June 30, 2021 | -0.1615 |
| March 31, 2021 | -0.1306 |
| December 31, 2020 | -1.317 |
| September 30, 2020 | -0.2917 |
| June 30, 2020 | -0.1516 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.105 |
| December 31, 2019 | -0.0262 |
| September 30, 2019 | -0.3495 |
| June 30, 2019 | -0.0811 |
| March 31, 2019 | -0.0784 |
| December 31, 2018 | -0.0767 |
| September 30, 2018 | -0.0745 |
| June 30, 2018 | -0.09 |
| March 31, 2018 | -0.1002 |
| December 31, 2017 | -0.09 |
| September 30, 2017 | -0.08 |
| June 30, 2017 | -0.08 |
| March 31, 2017 | -0.10 |
| December 31, 2016 | -0.25 |
| September 30, 2016 | -0.14 |
| June 30, 2016 | -0.28 |
| March 31, 2016 | -0.26 |
| March 31, 2015 | -4.411 |
| December 31, 2014 | -2.229 |
| September 30, 2014 | -0.60 |
| June 30, 2014 | -0.60 |
| March 31, 2014 | -0.24 |
| December 31, 2013 | -0.36 |
| September 30, 2013 | -4.56 |
| June 30, 2013 | -0.36 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 1.530 |
| Protect Pharmaceutical Corp. | -0.0004 |
| Champions Oncology, Inc. | -0.0306 |
| Medpace Holdings, Inc. | 4.250 |
| Charles River Laboratories International, Inc. | -0.0309 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.255M |
| Revenue (Quarterly) | 48.97M |
| Total Expenses (Quarterly) | 57.23M |
| Enterprise Value | 760.35M |
| Gross Profit Margin (Quarterly) | 39.66% |
| Profit Margin (Quarterly) | -16.86% |
| Earnings Yield | -4.83% |
| Normalized Earnings Yield | -4.861 |